Notably, these results also show that although CD4+ cells dominate the CD4+/CD8+ cell ratio in the blood and the tumor, the percentage of CD8+ T cells in the tumor increases, which indicates a potential expansion of these cells due to their engagement with the targeted tumor proteins. This evidence concerns the gene CD8A and neoplasm.